5'-Modified G-quadruplex forming oligonucleotides endowed with anti-HIV activity: synthesis and biophysical properties. 2007

Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
Dipartimento di Chimica Organica e Biochimica, Università degli Studi di Napoli Federico II, Complesso Universitario di Monte S. Angelo, via Cintia, 4, I-80126 Napoli, Italy.

Oligodeoxyribonucleotides of sequence d(5'TGGGAG3') carrying bulky aromatic groups at the 5' end were found to exhibit potent anti-HIV activity [Hotoda, H., et al. (1998) J. Med. Chem. 41, 3655-3663 and references therein]. Structure-activity relationship investigations indicated that G-quadruplex formation, as well as the presence of large aromatic substituents at the 5'-end, were both essential for their antiviral activity. In this work, we synthesized some representative examples of the anti-HIV active Hotoda's 6-mers and analyzed the resulting G-quadruplexes by CD, DSC, and molecular modeling studies, in comparison with the unmodified oligonucleotide. In the case of the sequence carrying the 3,4-dibenzyloxybenzyl (DBB) group, identified as the best candidate for further drug optimization, we developed an alternative protocol to synthesize the 5'-DBB-thymidine phosphoramidite building block in higher yields. The thermodynamic and kinetic parameters for the association/dissociation processes of the 5'-conjugated quadruplexes, determined with respect to the unmodified one, were discussed in light of the molecular modeling studies. The aromatic groups at the 5' position of d(5'TGGGAG3') dramatically enhance both the equilibrium and the rate of formation of the quadruplex complexes. The overall stability of the investigated quadruplexes was found to correlate with the reported IC50 values, thus furnishing quantitative evidence for the hypothesis that the G-quadruplex structures are the ultimate active species, effectively responsible for the biological activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D002152 Calorimetry, Differential Scanning Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. Differential Thermal Analysis, Calorimetric,Calorimetric Differential Thermal Analysis,Differential Scanning Calorimetry,Scanning Calorimetry, Differential
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
September 2015, Molecules (Basel, Switzerland),
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
February 2011, Chemical communications (Cambridge, England),
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
January 2000, Nucleic acids symposium series,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
September 2020, International journal of molecular sciences,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
January 2015, European journal of medicinal chemistry,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
October 1996, Bioorganic & medicinal chemistry,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
March 2018, Organic & biomolecular chemistry,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
February 2005, Chemistry & biodiversity,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
June 2023, Pharmaceutics,
Jennifer D'Onofrio, and Luigi Petraccone, and Eva Erra, and Luigi Martino, and Giovanni Di Fabio, and Lorenzo De Napoli, and Concetta Giancola, and Daniela Montesarchio
May 2023, Chembiochem : a European journal of chemical biology,
Copied contents to your clipboard!